Harold Hosker

462 total citations
21 papers, 351 citations indexed

About

Harold Hosker is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Physiology. According to data from OpenAlex, Harold Hosker has authored 21 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 5 papers in Epidemiology and 5 papers in Physiology. Recurrent topics in Harold Hosker's work include Inhalation and Respiratory Drug Delivery (8 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers) and Asthma and respiratory diseases (5 papers). Harold Hosker is often cited by papers focused on Inhalation and Respiratory Drug Delivery (8 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers) and Asthma and respiratory diseases (5 papers). Harold Hosker collaborates with scholars based in United Kingdom and China. Harold Hosker's co-authors include Henry Chrystyn, Philip Chetcuti, Dinesh Saralaya, John Stephenson, Paul A. Corris, Derek Lowe, C Michael Roberts, Stephen L. Chan, Michael Pearson and Peter M. Hawkey and has published in prestigious journals such as European Respiratory Journal, Thorax and Pharmaceutical Research.

In The Last Decade

Harold Hosker

20 papers receiving 326 citations

Peers

Countries citing papers authored by Harold Hosker

Since Specialization

Citations

This map shows the geographic impact of Harold Hosker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harold Hosker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harold Hosker more than expected).

Fields of papers citing papers by Harold Hosker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harold Hosker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harold Hosker. The network helps show where Harold Hosker may publish in the future.

Co-authorship network of co-authors of Harold Hosker

This figure shows the co-authorship network connecting the top 25 collaborators of Harold Hosker. A scholar is included among the top collaborators of Harold Hosker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harold Hosker. Harold Hosker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Inhalation characteristics of asthma patients, COPD patients and healthy volunteers with the Spiromax® and Turbuhaler® devices: a randomised, cross-over study 2015 ·BMC Pulmonary Medicine ·(unknown), Philip Chetcuti, Harold Hosker, Dinesh Saralaya, Henry Chrystyn	43
2	The Inhalation Characteristics of Patients When They Use Different Dry Powder Inhalers 2014 ·Journal of Aerosol Medicine and Pulmonary Drug Delivery ·(unknown), Philip Chetcuti, Harold Hosker, Dinesh Saralaya, John Stephenson, Henry Chrystyn	90
3	Inhalation characteristics with Spiromax® (S) versus Turbuhaler® (T) dry powder inhalers (DPI) in healthy adults (HA) and in patients with asthma (A) or COPD 2013 ·European Respiratory Journal ·(unknown), Philip Chetcuti, Harold Hosker, Dinesh Saralaya, Henry Chrystyn	3
4	Enhanced training on how to use a dry powder inhaler (DPI) improves the inhalation manoeuvre (IM) of patients with asthma (child 6-17 yrs and adult >17 yrs) or COPD and in healthy adults (HA) when they use a Spiromax® (S) and Turbuhaler® (T) DPI 2013 ·(unknown), Philip Chetcuti, Harold Hosker, Dinesh Saralaya, Henry Chrystyn	2
5	Objective measurement of inhalation profiles in patients using metered dose inhalers (MDIs) 2011 ·European Respiratory Journal ·(unknown), Philip Chetcuti, Harold Hosker, Dinesh Saralaya, Henry Chrystyn	1
6	Introducing the national COPD resources and outcomes project 2009 ·BMC Health Services Research ·(unknown), B.D.W. Harrison, Derek Lowe, R. Buckingham, N. A. Pursey, Harold Hosker, Jonathan Potter, C Michael Roberts	6
7	Determination of the Relative Bioavailability of Salbutamol to the Lungs Following Inhalation from Dry Powder Inhaler Formulations Containing Drug Substance Manufactured by Supercritical Fluids and Micronization 2007 ·Pharmaceutical Research ·(unknown), Marcel de Matas, Harold Hosker, Rahul Mukherjee, Ian Chi Kei Wong, Henry Chrystyn	26
8	Variability in the organisation and management of hospital care for COPD exacerbations in the UK 2006 ·Respiratory Medicine ·Harold Hosker, (unknown), Derek Lowe, Michael Pearson, C Michael Roberts	30
9	Survey of early discharge schemes from the 2003 UK National COPD Audit 2006 ·Respiratory Medicine ·(unknown), Derek Lowe, Harold Hosker, (unknown), M Pearson, C Michael Roberts	16
10	Choice of add-on therapy in asthma — another inhaler or a tablet/syrup? A survey of 1415 UK asthmatics 2001 ·Primary Care Respiratory Journal ·J M Tuggey, Harold Hosker, P Chetcuti, K. Brownlee, (unknown), Christopher K. Macgowan	1
11	Slowing the Rate of Acute Medical Admissions 1997 ·Journal of the Royal College of Physicians of London ·Peter Wanklyn, Harold Hosker, (unknown), P W Belfield	15
12	165 A phase II study of an intensive, modified ICE regimen in patients with good prognosis small cell lung cancer 1997 ·Lung Cancer ·(unknown), (unknown), Janice Brown, (unknown), M F Muers, Michael Peake, Harold Hosker	1
13	The prevalence and clinical significance of pulmonary infection due to non-tuberculous mycobacteria in Hong Kong 1995 ·Respiratory Medicine ·Harold Hosker, (unknown), (unknown), (unknown), Stephen L. Chan	47
14	Assessment and provision of home nebulizers for chronic obstructive pulmonary disease (COPD) in the Yorkshire region of the U.K. 1995 ·Respiratory Medicine ·Harold Hosker, C. Teale, Michael Greenstone, M F Muers	3
15	Fortnightly Review: Management of community acquired lower respiratory tract infection 1994 ·BMJ ·Harold Hosker, (unknown), Peter M. Hawkey	16
16	<i>Mycoplasma pneumoniae</i> Infection in Hong Kong – Clinical and Epidemiological Features during an Epidemic 1993 ·Respiration ·Harold Hosker, John S. Tam, Christopher H.S. Chan, Christopher Lai	11
17	Alcohol and health: do we know enough? 1990 ·PubMed ·(unknown), Harold Hosker, Hamish Foster, C O Record	3
18	Assessment of phagocytic function using chemiluminescence 1989 ·Blood Reviews ·Harold Hosker, (unknown), Paul A. Corris	29
19	Incidence and types of acute viral hepatitis in Newcastle upon Tyne 1988 ·Postgraduate Medical Journal ·Harold Hosker, David C. Lindsay, (unknown), A. A. Codd, (unknown), C O Record	2
20	Ectopic right upper lobe bronchus as a cause of breathlessness. 1987 ·Thorax ·Harold Hosker, (unknown), G N Morritt	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact